Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis

Currently, there is no effective vaccine to halt HIV transmission. However, pre-exposure prophylaxis (PrEP) with the drug combination Truvada can substantially decrease HIV transmission in individuals at risk. Despite its benefits, Truvada-based PrEP is expensive and needs to be taken once-daily, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Duwal, Sulav, Dickinson, Laura, Khoo, Saye, von Kleist, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370240/
https://www.ncbi.nlm.nih.gov/pubmed/30699105
http://dx.doi.org/10.1371/journal.pcbi.1006740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370240/
https://www.ncbi.nlm.nih.gov/pubmed/30699105
http://dx.doi.org/10.1371/journal.pcbi.1006740

Ejemplares similares